Effect of zinc or copper supplementation on the efficacy and sustainability of botulinum toxin A "Botox" injection in masseter muscle of albino rats

J Stomatol Oral Maxillofac Surg. 2025 Oct;126(5):102156. doi: 10.1016/j.jormas.2024.102156. Epub 2024 Nov 15.

Abstract

Objectives: This study aimed to evaluate whether oral zinc or copper supplementation affected the efficacy and sustainability of botulinum toxin-A (BTX-A) injection in masseter muscle of albino rats.

Materials and methods: 32 adult male albino rats were allocated equally into four groups: group I (control), group II received 10U BTX-A injection, group III received 10U BTX-A injection + zinc (1 mg, 4 days pre-injection), and group IV received 10U BTX-A injection + copper (0.04 mg, 7 days post-injection). Rats were euthanized at 2 and 12 weeks (4 rats per subgroup) after injection. The masseter muscle was examined via histological, histochemical, histomorphometrical and real-time polymerase chain reaction (qRT-PCR) analyses.

Results: The histopathological results of the BTX-A group showed atrophied muscle fibers with increased atrophy with time compared to the control group. The BTX-A + zinc group displayed more atrophy compared to BTX-A group. Conversely, the BTX-A + copper group demonstrated improved histology of muscle fibers compared to BTX-A and BTX-A + zinc groups. Histomorphometric analysis of Masson trichrome staining at 2 and 12 weeks revealed that collagen area percentage was the highest in the BTX-A + copper and control groups, followed by BTX-A and BTX-A + zinc groups. At 12 weeks, the nuclear factor kappa beta (NF-κB) mRNA expression was significantly higher in BTX-A + zinc and BTX-A groups compared to BTX-A + copper group and relative to the control group.

Conclusion: Zinc supplementation significantly improved the effectiveness and durability of BTX-A, whereas copper supplementation reduced its efficacy.

Keywords: Botulinum toxin type A; Copper; Masseter muscle; Zinc.

MeSH terms

  • Animals
  • Botulinum Toxins, Type A* / administration & dosage
  • Botulinum Toxins, Type A* / pharmacology
  • Copper* / administration & dosage
  • Copper* / pharmacology
  • Dietary Supplements*
  • Injections, Intramuscular
  • Male
  • Masseter Muscle* / drug effects
  • Masseter Muscle* / pathology
  • Muscular Atrophy
  • Neuromuscular Agents* / administration & dosage
  • Neuromuscular Agents* / pharmacology
  • Rats
  • Real-Time Polymerase Chain Reaction
  • Zinc* / administration & dosage
  • Zinc* / pharmacology

Substances

  • Botulinum Toxins, Type A
  • Copper
  • Zinc
  • Neuromuscular Agents